Rohtesh S. Mehta, MD, MPH, MS

Rohtesh S. Mehta, MD, MPH, MS

Rohtesh S. Mehta, MD, MPH, MS

  • Physician, Fred Hutch
  • Associate Professor, University of Washington School of Medicine
  • Associate Professor, Clinical Research Division, Fred Hutch

Medical Oncology

“Blood and marrow transplant is the only treatment that has the potential to cure several conditions, yet it can also lead to serious complications like graft-versus-host disease (GVHD).”

— Dr. Mehta

What are you focused on at Fred Hutch?

One of the areas of my clinical and research focus has been to study the ways we can reduce the risk of Graft-versus-host disease (GVHD) through improved donor and graft selection, since these factors are modifiable. I am also interested in the treatment of acute and chronic GVHD.

What are some of the things that interest you about preventing and treating GVHD?

GVHD can have significant and enduring impact on quality of life even in those who survive it. Caring for GVHD patients has been challenging in the recent past partly due to lack of therapeutics. Even though transplantations started more than half a century ago, it wasn’t until 2017 that the first drug for the treatment of refractory chronic GVHD was approved by the U.S. Food and Drug Administration (FDA). Two new drugs were also approved almost back-to-back in 2021, and several new medications are currently being studied. I am very excited to be a part of changing the treatment paradigm.

Provider Background

Specialty: Medical Oncology

Area of clinical practice

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Graft-versus-host disease

I am a medical oncologist and hematologist who sees patients at the South Lake Union Clinic, UW Medical Center – Montlake and UW Medical Center – Northwest.

I am also focused on clinical research, and have published many studies comparing different donor/graft sources through the Center for International Blood and Marrow Transplant Research registry as well as single-center analysis. In addition, I have led prospective clinical trials for the prevention of GVHD and treatment of chronic GVHD.

Diseases Treated



Education, Experience and Certifications

Medical School
Government Medical College, Patiala, Punjab, India

University of Pittsburgh Medical Center

MPH, Epidemiology and Biostatistics, University of North Texas Health Science Center; MS, Clinical Trials, University of Pittsburgh

Board Certifications
Internal Medicine, 2009; Hospice and Palliative Medicine, 2010; Hematology, 2014; Medical Oncology, 2014

MD Anderson Stem Cell Transplant Harvey Hero Award, 2017; MD Anderson Top Performer Award, 2019

Clinical Trials

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch doctors. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Find a Clinical Trial


Many of our Fred Hutch doctors conduct ongoing research to improve standards of patient care. Their work is evaluated by other doctors and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch provider has written.

View Dr. Mehta's Publications

Your Care Team

At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.


Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with providers.

Email or call 206.667.2210